Results 11 to 20 of about 33,871 (216)
, 2023 In vitro study suggested that A2BR agonists can induce PD-L1 expression through induction of NF-kB pathway, while the inhibitors of NF-kB pathway can partially reverse the promoting effect of A2BR on PD-L1 expression.
Wang Bing (15466217)
core +1 more source
Perilesional sites of OSCC had altered P-cadherin expression [PDF]
, 2016 Epithelial cells at surgical free margins are considered to be free of pathology at the morphological level. However, they might be associated with molecular changes when considering clonal expansion of pre-neoplastic cells in a particular tumor field ...
Dena N. Mohammad
core +2 more sources
Advances of Non-coding RNA in Oral Cancer
Zhongliu Fangzhi Yanjiu, 2022 Oral cancer is a common head and neck malignant tumor. Its molecular mechanism of pathogenesis is complex and needs further exploration. Non-coding RNAs account for more than 95% of human transcripts and include microRNAs, lncRNAs, and circRNAs. They are
FU Yuting, YANG Wenjun, JIANG Binyuan
doaj +1 more source
Galectin 3 expression in primary oral squamous cell carcinomas
BMC Cancer, 2017 Background Immunologic factors can promote the progression of oral squamous cell carcinomas (oscc). The phylogenetic highly conserved protein Galectin 3 (Gal3) contributes to cell differentiation and immune homeostasis.
Manuel Weber +8 more
doaj +1 more source
Open Medicine, 2023 Oral squamous cell carcinoma (OSCC) is a common tumor in the world. Despite the rapid development of medical care, OSCC is also accompanied by high incidence and mortality every year.
Huang Juan +4 more
doaj +1 more source
Asian Journal of Oncology, 2022 Objective Locoregional recurrence in oral squamous cell carcinoma (OSCC) is a major concern that leads to metastasis. Its detection at earliest stage is very important to increase the overall survival of the patient.
Seema Nayak +6 more
doaj +1 more source
Neoadjuvant chemotherapy in oral cancer: Current status and future possibilities
Cancer Research, Statistics, and Treatment, 2020 Eighty-five percent of oral cavity cancers present as locally advanced disease and are treated with multimodality approach. Patients who can undergo radical resection have the best outcomes, although the overall results are still unsatisfactory ...
Alok Goel, Anshul Singla, Kumar Prabhash
doaj +1 more source
Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: There is a need for development and use of diagnostic aids that help the dental specialist more readily identify and assess Potentially Malignant Epithelial Lesions (PMELs) and Oral Squamous Cell Carcinoma (OSCC).
Neha Vashisht +5 more
doaj +1 more source
Cancer Management and Research, 2023 Ankita Sharma, Srikant Natarajan, Nidhi Manaktala, Karen Boaz, Nandita KP, Amitha Lewis, Shweta Yellapurkar Department of Oral Pathology, Manipal College of Dental Sciences Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka ...
Sharma A +6 more
doaj
Assessment of the Protective Effect of Myricetin in Chemically Induced Oral Squamous Cell Carcinoma in Hamsters [PDF]
SINAI International Scientific JournalIntroduction: Scientific studies indicate that biologically active compounds are present in medicinal plants, and antioxidant agents are effective in treating several diseases, including cancer.
Nadia Radi +3 more
doaj +1 more source